Lung Cancer Screening 2nd Edition
What to expect
This advanced ESOR Special Course offers an in-depth exploration of lung cancer screening (LCS) across Europe and beyond.
Through lectures by leading international experts, participants will gain a comprehensive understanding of current evidence, implementation strategies, and practical challenges in LCS.
Combining scientific insight with real-world experience, the course equips radiologists with the tools to play an active role in screening programmes—enhancing early detection, patient communication, and multidisciplinary collaboration.
All Special Focus Courses, and many more, are available on-demand for Premium Education Package subscribers.
Accreditation
This course has been granted 10 European CME credit (ECMEC®s) by the European Accreditation Council for Continuing Medical Education (EACCME).
Certificates with CME credits will be issued only after watching the live stream and completing an online evaluation form.
No CME credits will be available for watching on demand.
We work with impartiality and transparency. Find the steering committee disclosure forms here →
learning objectives
Describe current eligibility criteria and international approaches to lung cancer screening.
Apply evidence-based strategies for nodule management and quality assurance in LCS.
Recognise additional thoracic and cardiovascular findings relevant to screening participants.
Evaluate the role and limitations of AI in lung cancer screening workflows.
Communicate screening results effectively and empathetically to participants.
programme
coming soon
Programme
all times local
| 12:30 – 13:00 | Lung Cancer Screening: The Korean Experience Jin Mo Goo, Seoul/KR |
| 13:00 – 13:30 | Willingness to Participate in Lung Cancer Screening: Key Motivational Factors Marteen Ijzerman, Rotterdam/NL |
| 13:30 – 14:00 | Screening as a Mindset: Moving Beyond Diagnostic Thinking Marjolein Heuvelmans, Groningen/NL |
| 14:00 – 14:30 | Defining Who to Screen: Overview of the Different Approaches to Lung Cancer Screening Eligibility Joanna Chorostowska-Wynimko, Warsaw/PL |
| 14:30 – 15:00 | Q&A Session |
| 15:00 – 15:30 | Break |
| 15:30 – 16:00 | The ESTI Nodule Management Recommendations: Focusing on Nodule Aggressiveness Helmut Prosch, Vienna/AT |
| 16:00 – 16:30 | Quality first: Implementing Quality Assurance in LCS Programmes Anna Kerpel-Fronius, Budapest/HU |
| 16:30 – 17:00 | Integrating Coronary Artery Calcium Scoring into Lung Cancer Screening: How and why Rozemarijn Vliegenthart, Groningen/NL |
| 17:00 – 17:30 | Case-Based Session #1 Arjun Nair, London/UK |
| 17:30 – 18:00 | Q&A Session |
all times local
| 12:30 – 13:00 | The Radiologist’s Role in Lung Cancer Screening: From Image to Impact Annemiek Snoeckx, Antwerp/BL |
| 13:00 – 13:30 | Uncovering More Than Nodules: Parenchymal Abnormalities in LCS Participants Cornelia Schaefer-Prokop, Amersfoort/NL |
| 13:30 – 14:00 | Lung Cancer Screening: the UK’s Longstanding Experience and Lessons Learned David Baldwin, Nottingham/UK |
| 14:00 – 14:30 | Lung Cancer Screening: The HANSE Study Experience Jens Vogel Claussen, Hannover/DE |
| 14:30 – 15:00 | Q&A Session |
| 15:00 – 15:30 | Break |
| 15:30 – 16:00 | Communicating Results to Participants: Tips and Best Practices Marie-Pierre Revel, Paris/FR |
| 16:00 – 16:30 | AI in Lung Cancer Screening: Potential, Performance and Limitations Colin Jacobs, Nijmegen/NL |
| 16:30 – 17:00 | Ten Years of Lung Cancer Screening Participation in I-ELCAP Luis Seijo, Navarra/ES |
| 17:00 – 17:30 | Case-Based Session #2 Roberta Ledda, Parma/IT |
| 17:30 – 18:00 | Q&A Session |
Fees
free of charge
For all radiologists, radiologists-in-training and radiographers, incl. those who are not yet members of the ESR.
the world of radiology is yours
Get inspired by our Scholar- and Fellowship programmes and find out where you will go next!
